What is he best known for?
The fields of study he is best known for:
His main research concerns Angiogenesis, Cell biology, Molecular biology, Receptor tyrosine kinase and Immunology.
Daniel J. Dumont has researched Angiogenesis in several fields, including Endothelial stem cell, Vasculogenesis and Endocrinology.
His Cell biology research incorporates elements of Embryonic stem cell, Mesoderm and Vascular endothelial growth factor.
His Molecular biology study integrates concerns from other disciplines, such as Receptor, Cell surface receptor, Tyrosine kinase, Protein tyrosine phosphatase and FLT4.
His work deals with themes such as COS cells and TIE1, which intersect with Receptor tyrosine kinase.
While the research belongs to areas of Immunology, he spends his time largely on the problem of Pathology, intersecting his research to questions surrounding Targeted therapy.
His most cited work include:
- Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. (1250 citations)
- Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. (902 citations)
- Cardiovascular Failure in Mouse Embryos Deficient in VEGF Receptor-3 (780 citations)
What are the main themes of his work throughout his whole career to date?
Daniel J. Dumont mainly focuses on Cell biology, Angiopoietin receptor, Angiogenesis, Receptor tyrosine kinase and Immunology.
He combines subjects such as Endothelial stem cell, Embryonic stem cell and Cellular differentiation with his study of Cell biology.
The study incorporates disciplines such as Transgene, Agonist, Ischemia, Internalization and Angiopoietin in addition to Angiopoietin receptor.
His Angiogenesis research is multidisciplinary, relying on both Endocrinology and Angiopoietins.
His biological study spans a wide range of topics, including ROR1, Tyrosine kinase, Protein tyrosine phosphatase and Tyrosine phosphorylation.
In Immunology, Daniel J. Dumont works on issues like Endothelium, which are connected to Lymphatic Endothelium and Lymphatic system.
He most often published in these fields:
- Cell biology (58.59%)
- Angiopoietin receptor (41.41%)
- Angiogenesis (32.03%)
What were the highlights of his more recent work (between 2013-2021)?
- Inflammation (14.84%)
- Immunology (34.38%)
- Pharmacology (7.81%)
In recent papers he was focusing on the following fields of study:
Daniel J. Dumont mainly investigates Inflammation, Immunology, Pharmacology, Angiopoietin receptor and TLR4.
The concepts of his Inflammation study are interwoven with issues in Endothelial stem cell, Clonogenic assay, Radiation therapy and Wound healing.
His Immunology research incorporates themes from ARDS, Cardiopulmonary bypass, Allele and Intensive care unit.
The Pharmacology study combines topics in areas such as Agonist, Vasculotide, Creatinine and Endothelium.
His research in Angiopoietin receptor intersects with topics in Vascular endothelial growth factor A, Receptor tyrosine kinase, Cell biology and Angiopoietin.
His Angiopoietin research is multidisciplinary, incorporating elements of Molecular mimicry, Transgene, Angiopoietin-1, Phenotype and Atopic dermatitis.
Between 2013 and 2021, his most popular works were:
- Gene control of tyrosine kinase TIE2 and vascular manifestations of infections (60 citations)
- The Synthetic Tie2 Agonist Peptide Vasculotide Protects Renal Vascular Barrier Function In Experimental Acute Kidney Injury. (26 citations)
- Vasculotide, an Angiopoietin-1 mimetic, reduces acute skin ionizing radiation damage in a preclinical mouse model (16 citations)
In his most recent research, the most cited papers focused on:
His primary areas of investigation include Inflammation, Clonogenic assay, Radiation therapy, Bioluminescence imaging and Matrigel.
His Inflammation research includes themes of Angiopoietin receptor, Neuroprotection and Monocyte.
Daniel J. Dumont has researched Clonogenic assay in several fields, including Wound healing, Granulation tissue, Endothelial stem cell and Pathology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
